Announced details
Ischemic cardiomyopathy, regenerative medicine and cardiovascular medicine
Conference accepting a presentation on our research findings and conference organizer
An organization that hosts academic conferences in the cardiovascular field. Other details, including its location, representative, capital and year established, are not disclosed.
Boston, Massachusetts, United States (conference venue)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Basic Cardiovascular Sciences Scientific Sessions 2026 (BCVS 2026), hosted by the American Heart Association (AHA)
| Item | Details |
|---|---|
| Names of Products / Services Covered | Minimally Invasive Regenerative Medicine Approach for Ischemic Cardiomyopathy Using Regenerative Myocardial Organoids |
| Counterparty | American Heart Association (AHA) |
| Counterparty overview | An organization that hosts academic conferences in the cardiovascular field. Other details, including its location, representative, capital and year established, are not disclosed. |
| Relationship with the Company | Conference accepting a presentation on our research findings and conference organizer |
| Launch date | 13 to 16 July 2026 (scheduled) |
| Applicable area | Ischemic cardiomyopathy, regenerative medicine and cardiovascular medicine |
| Location | Boston, Massachusetts, United States (conference venue) |
| Source | Basic Cardiovascular Sciences Scientific Sessions 2026 (BCVS 2026), hosted by the American Heart Association (AHA) |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To deepen collaboration with researchers and healthcare professionals worldwide through the presentation at this conference and pursue the early practical application of this therapeutic technology.